Companies: 10,795·Total market cap: $144.5T
Merus N.V.

Merus N.V.

MRUSNASDAQHealthcare
$90.00
+$0.00(+0.00%)
Market Cap$6.8B
P/E Ratio
52W High$97.14
52W Low$33.19

Merus N.V. (MRUS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · MRUS · as of Feb 27, 2025

Latest filing snapshot

260
+88+51.16%vs prior year

Merus N.V. (MRUS) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
260
Change (1Y)
+88
Growth % (1Y)
+51.16%
Revenue / Employee
$134.2K
Net Income / Employee
$-799.4K
Market Cap
$6.8B

MRUS Employee Count

2016 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-02-27260+88+51.16%
2024-02-28172+8+4.88%
2023-02-28164+43+35.54%
2022-02-28121+28+30.11%
2021-03-1693+6+6.90%
2020-03-1687-11-11.22%
2019-04-0398+15+18.07%
2018-04-3083+32+62.75%
2017-04-2851

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Jazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc
2,800
#2
Axsome Therapeutics, Inc.
AXSM
Axsome Therapeutics, Inc.
712
#3
Corcept Therapeutics Incorporated
CORT
Corcept Therapeutics Incorporated
500
#4
Cytokinetics, Incorporated
CYTK
Cytokinetics, Incorporated
498
#5
Halozyme Therapeutics, Inc.
HALO
Halozyme Therapeutics, Inc.
350
#6
Merus N.V.
MRUS
Merus N.V.YOU
260
#7
Abivax S.A.
ABVX
Abivax S.A.
69
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · MRUS peer comparison

About MRUS employees

MRUS Employees · Headcount

Merus N.V. (MRUS) employee data is sourced from the annual SEC 10-K filing. As of 2024, Merus N.V. had 260 full-time employees globally. Full-time employees only. Global consolidated headcount.

Merus N.V. employs 260 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $134,151, reflecting the company's operational efficiency.

Merus N.V.'s workforce increased by 88 (51.16%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Merus N.V.'s revenue per employee of $134,151 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

MRUS Employees · 5 questions

As of the latest SEC 10-K filing (2024), Merus N.V. had 260 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Merus N.V. employee counthow many employees does Merus N.V. haveMRUS total employees 2024

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-02-27